Yukihiro Toi

机构：Sendai Kousei Hospital · ORCID：0000-0001-5983-3531

发表论文 100 篇 · 总被引 1804 次 · h-index 11

代表论文

• Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED) (2025 · ESMO Open · 被引 4)
• Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424L (2025 · Clinical Lung Cancer · 被引 2)
• Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non–small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102) (2025 · European Journal of Cancer · 被引 2)
• Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion) (2026 · Lung Cancer · 被引 1)
• Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non–small cell lung cancer: exploratory analysis of a prospective observational study (2026 · Lung Cancer · 被引 1)
• Cardiovascular adverse events in patients with lung cancer treated with immune checkpoint inhibitors: a nationwide database study (2025 · The Oncologist · 被引 1)